Approval · Notice of Compliance 9023 · 2007
OMNISCAN: Notice of Compliance 9023
Issued September 14, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9023
- Date
- September 14, 2007
- Company
- Ge Healthcare Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication - use in magnetic resonance angiography for the detection and localization of stenosis in vessels supplying an organ and vessels with turbulent flow
- Therapeutic class
- Contrast enhancement agent for magnetic resonance imaging (mri)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OMNISCAN | Not yet assigned | — |
Medicinal ingredients
- GADODIAMIDE 287 MG per ML